PECAM1 and neoplasm: We additionally tested whether XEN445 administration could normalize the glucose uptake defect in tumor ECs in vivo by intravenously injecting the fluorescent glucose analog 2NBDG in tumor-bearing mice and determining the colocalization of fluorescent glucose within CD31+ ECs.